Dr Reddys Labs Quarterly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Dec-2022	Sep-2022	Jun-2022	Mar-2022
Gross Sales	6296.90	6,770	6305.70	5215.40	5436.80
Excise Duty	--	--	--	--	--
Net Sales	6296.90	6,770	6305.70	5215.40	5436.80
Other Operating Income	18.30	19.90	26.10	17.50	38.10
Other Income	146.10	64.60	54.80	863.30	132.40
Total Income	6461.30	6854.50	6386.60	6096.20	5607.30
Total Expenditure	4781.30	4851.30	4432.90	4291.70	5023.90
PBIDT	1,680	2003.20	1953.70	1804.50	583.40
Interest	35.40	41.80	30.90	34.70	31.50
PBDT	1644.60	1961.40	1922.80	1769.80	551.90
Depreciation	315.50	323.70	309.20	301.80	293
Minority Interest Before NP	--	--	--	--	--
Tax	427.90	309.60	367.40	(290.50)	606.40
Deferred Tax	(58.90)	84.20	132	569.50	(444.50)
Reported Profit After Tax	960.10	1243.90	1114.20	1,189	97
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	960.10	1243.90	1114.20	1,189	97
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	960.10	1243.90	1114.20	1,189	97
EPS (Unit Curr.)	57.79	74.91	67.13	71.64	5.84
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	83.30	83.30	83.20	83.20	83.20
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	26.68	29.59	30.98	34.60	10.73
PBDTM(%)	26.12	28.97	30.49	33.93	10.15
PATM(%)	15.25	18.37	17.67	22.80	1.78

QuickLinks for Dr Reddys Laboratories Ltd.